These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 2953243)
21. Ovarian immunoreactive beta-endorphin and estrous cycle in the rat. Lolait SJ; Autelitano DJ; Lim AT; Smith AI; Toh BH; Funder JW Endocrinology; 1985 Jul; 117(1):161-8. PubMed ID: 3159564 [TBL] [Abstract][Full Text] [Related]
22. Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Magoffin DA; Jakimiuk AJ Hum Reprod; 1998 Oct; 13(1O):2693-8. PubMed ID: 9804215 [TBL] [Abstract][Full Text] [Related]
23. Anti-müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. Stubbs SA; Hardy K; Da Silva-Buttkus P; Stark J; Webber LJ; Flanagan AM; Themmen AP; Visser JA; Groome NP; Franks S J Clin Endocrinol Metab; 2005 Oct; 90(10):5536-43. PubMed ID: 16030171 [TBL] [Abstract][Full Text] [Related]
24. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. Pellatt L; Hanna L; Brincat M; Galea R; Brain H; Whitehead S; Mason H J Clin Endocrinol Metab; 2007 Jan; 92(1):240-5. PubMed ID: 17062765 [TBL] [Abstract][Full Text] [Related]
25. Elevated plasma levels of beta-endorphin in a group of women with polycystic ovarian disease. Aleem FA; McIntosh T Fertil Steril; 1984 Nov; 42(5):686-9. PubMed ID: 6092152 [TBL] [Abstract][Full Text] [Related]
26. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683 [TBL] [Abstract][Full Text] [Related]
27. Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography. Järvelä IY; Sladkevicius P; Kelly S; Ojha K; Campbell S; Nargund G Fertil Steril; 2004 Nov; 82(5):1358-63. PubMed ID: 15533360 [TBL] [Abstract][Full Text] [Related]
28. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588 [TBL] [Abstract][Full Text] [Related]
29. Formation and early development of follicles in the polycystic ovary. Webber LJ; Stubbs S; Stark J; Trew GH; Margara R; Hardy K; Franks S Lancet; 2003 Sep; 362(9389):1017-21. PubMed ID: 14522531 [TBL] [Abstract][Full Text] [Related]
30. 11 beta-hydroxyandrostenedione in plasma, follicular fluid, and granulosa cells of women with normal and polycystic ovaries. Owen EJ; Holownia P; Conway GS; Jacobs HS; Honour JW Fertil Steril; 1992 Oct; 58(4):713-8. PubMed ID: 1426315 [TBL] [Abstract][Full Text] [Related]
31. Pressure pain threshold and β-endorphins plasma level are higher in lean polycystic ovary syndrome women. Kiałka M; Milewicz T; Mrozińska S; Rogatko I; Sztefko K; Majewska R Minerva Endocrinol; 2017 Dec; 42(4):297-305. PubMed ID: 27603705 [TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor binding proteins in ovarian follicles from women with polycystic ovarian disease: cellular source and levels in follicular fluid. San Roman GA; Magoffin DA J Clin Endocrinol Metab; 1992 Oct; 75(4):1010-6. PubMed ID: 1383254 [TBL] [Abstract][Full Text] [Related]
34. Polycystic ovarian disease: US features in 104 patients. Yeh HC; Futterweit W; Thornton JC Radiology; 1987 Apr; 163(1):111-6. PubMed ID: 3547491 [TBL] [Abstract][Full Text] [Related]
35. Demonstration of immunoreactive beta-endorphin- and gamma 3-melanocyte-stimulating hormone-related peptides in the ovaries of neonatal, cyclic, and pregnant mice. Shaha C; Margioris A; Liotta AS; Krieger DT; Bardin CW Endocrinology; 1984 Jul; 115(1):378-84. PubMed ID: 6329660 [TBL] [Abstract][Full Text] [Related]
36. Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. Welt CK; Taylor AE; Fox J; Messerlian GM; Adams JM; Schneyer AL J Clin Endocrinol Metab; 2005 Oct; 90(10):5582-7. PubMed ID: 16030174 [TBL] [Abstract][Full Text] [Related]
37. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome. Schipper I; Rommerts FF; Ten Hacken PM; Fauser BC J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511 [TBL] [Abstract][Full Text] [Related]
38. Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability. Teissier MP; Chable H; Paulhac S; Aubard Y Hum Reprod; 2000 Dec; 15(12):2471-7. PubMed ID: 11098013 [TBL] [Abstract][Full Text] [Related]
39. A comparison of follicular fluid levels of insulin-like growth factor-1 in normal dominant and cohort follicles, polycystic and multicystic ovaries. Eden JA; Jones J; Carter GD; Alaghband-Zadeh J Clin Endocrinol (Oxf); 1988 Sep; 29(3):327-36. PubMed ID: 3251671 [TBL] [Abstract][Full Text] [Related]
40. Steroidogenic acute regulatory protein (StAR) in the ovaries of healthy women and those with polycystic ovary syndrome. Kahsar-Miller MD; Conway-Myers BA; Boots LR; Azziz R Am J Obstet Gynecol; 2001 Dec; 185(6):1381-7. PubMed ID: 11744913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]